The SVIR compartmental model extends the classical SIR structure to explicitly capture the dynamics of vaccination—an essential tool for evaluating public health interventions against infectious diseases. By integrating a vaccinated class, this framework enables rigorous quantification of how immunization campaigns alter transmission pathways, shift herd immunity thresholds, and inform optimal vaccine deployment strategies.
🗂️ Compartmental Structure
The total population N(t) = S(t) + V(t) + I(t) + R(t) is partitioned into four mutually exclusive states:
- Susceptible (S): Individuals who can contract the disease; they transition to I upon infection or to V upon vaccination.
- Vaccinated (V): Individuals who have received a vaccine. In the baseline model, they gain partial or full immunity, depending on vaccine efficacy.
- Infectious (I): Infected individuals who are capable of transmitting the pathogen.
- Recovered (R): Individuals who have cleared the infection and are assumed immune (at least over the modeling horizon).
💡 Note: The model can be extended to include waning immunity (V → S or R → S), breakthrough infections (V → I), or multi-dose schedules.
🧮 Mathematical Formulation (Deterministic ODE System)
Assuming a closed population with mass-action transmission and constant total size (no vital dynamics), the core SVIR dynamics are governed by:
dS/dt = -(β S I)/N - ω S
dV/dt = ω S - ζ V
dI/dt = (β S I)/N - γ I
dR/dt = γ I + ζ V
Key parameters:
- β: Transmission rate (per contact per unit time)
- ω: Vaccination rate (fraction of susceptibles vaccinated per unit time)
- γ: Recovery rate (inverse of infectious period)
- ζ: Rate at which vaccinated individuals gain full, stable immunity (if ζ = 0, V is a terminal immune state; if modeling waning immunity, a term δ V may feed back to S)
For imperfect vaccines with efficacy ε ∈ [0,1], the force of infection on vaccinated individuals is reduced by (1 – ε), or the compartment V may include a sub-flow to I at rate (1 – ε)(β V I)/N.
📈 Plausible Parameter Ranges (General Viral Disease Context)
| Parameter | Symbol | Typical Range | Interpretation |
|---|---|---|---|
| Transmission rate | β | 0.3 – 2.5 day⁻¹ | Varies by pathogen (e.g., higher for measles, lower for seasonal flu) |
| Recovery rate | γ | 0.1 – 0.5 day⁻¹ | Corresponds to infectious period of 2–10 days |
| Basic reproduction number | R₀ = β/γ | 1.2 – 18 | Measles: ~12–18; Influenza: ~1.3; SARS-CoV-2 (ancestral): ~2.5–4 |
| Vaccination rate | ω | 0.001 – 0.1 day⁻¹ | Reflects campaign intensity (e.g., 0.01 = 1% of susceptibles vaccinated daily) |
| Vaccine efficacy | ε | 0.4 – 0.95 | mRNA vaccines vs. SARS-CoV-2: ~0.9; Influenza vaccines: ~0.4–0.6 |
⚠️ These values are context-dependent and must be calibrated to specific outbreaks, regions, and vaccine types.
⚖️ Applicability & Key Limitations
✅ When to use SVIR:
- Evaluating mass vaccination campaigns in closed or semi-closed populations
- Estimating critical vaccination coverage needed for herd immunity
- Formulating optimal control problems for vaccine allocation
- Studying diseases where infection confers long-term immunity
❌ Key limitations:
- Assumes homogeneous mixing (ignores contact networks, spatial heterogeneity)
- Baseline model presumes instantaneous, lifelong immunity post-vaccination (often unrealistic)
- Does not distinguish between asymptomatic/presymptomatic transmission
- Lacks age or risk-stratification unless extended (e.g., multi-group SVIR)
- Cannot capture immune escape or variant-driven changes in β or ε without time-varying parameters
🔍 For realistic policy analysis, SVIR is often embedded in stochastic, age-structured, or network-based frameworks.
📖 Key References
- Liu, X., Takeuchi, Y., & Iwami, S. (2008). SVIR epidemic models with vaccination strategies. Journal of Theoretical Biology.
- Turkyilmazoglu, M. (2022). An extended epidemic model with vaccination: Weak-immune SIRVI. Chaos, Solitons & Fractals.
- Enayati, S., & Ozaltin, O. Y. (2020). Optimal influenza vaccine distribution with equity. European Journal of Operational Research.
- Saad-Roy, C. M., Wagner, C. E., et al. (2020). Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years. Science.
- Tuong, T. D., Nguyen, D. H., & Nguyen, N. N. (2024). Stochastic multi-group epidemic SVIR models: Degenerate case. Journal of Mathematical Analysis and Applications.